Pharmtech & Ingredients – the main event for the future of pharmaceuticals

The 21st international exhibition of equipment, raw materials and technologies for pharmaceutical production went down a storm from 19-22 November 2019

Pharmtech & Ingredients is an exhibition of high importance to the pharmaceutical industry, promoting production and cooperation between international innovators and Russian medicine producers.

The exhibition’s opening ceremony was attended by senior industry figures, among whom were:
  • Vadim Kulikov, Deputy General Director of the Agency of Technological Development
  • Binaya Srikanta Pradhan, Deputy Chief of Mission at the Indian Embassy in Russia
  • Viktor Dmitriev, General Director of the Association of Russian Pharmaceutical Manufacturers (ARPM)
  • Oleg Malakhov, Member of the General Council, Chairman of the Kursk Regional Branch of the All-Russian Public Organisation Delovaya Rossiya
  • Alexey Martynov, President of the Biomedical Cell Products Manufacturers’ Association

In his welcoming address, Viktor Dmitriev noted that, “it has become a good tradition to discuss the year in review at Pharmtech & Ingredients. Today Pharmtech is not only an exhibition of achievements, but also the main event for the future of pharmaceuticals.”

This year, the show featured 7% more exhibitors – 479 companies from 33 countries, including over 100 first-time exhibitors. The total exhibition area increased 6% to reach 19,675 sqm. Germany, Switzerland, India and China presented national stands, with the number of Chinese companies doubling compared to last year.

During the show, Swiss President Ueli Maurer arrived in Russia on an official visit to discuss with Russian President Vladimir Putin and Prime Minister Dmitry Medvedev issues of Russian-Swiss cooperation in trade, economics, scientific, technical, investment, cultural and humanitarian areas, including how to make it easier for small and medium Swiss businesses to enter the Russian market. Mr Maurer’s visit was broadcast on the television channel SRF, with coverage including the Swiss stand at Pharmtech & Ingredients and exhibitor interviews. The Swiss pavilion featured 15 companies, a number that increases every year. This is indicative of the trend towards the development of cooperation, outlined by the presidents of Russia and Switzerland.

Over the four days, 8,231 visitors from 50 countries and 62 regions of Russia attended Pharmtech to discover exhibitors’ innovative technologies and solutions to optimise production processes.

The exhibition’s business programme was attended by 1,128 professionals and included issues provoking animated discussions among pharma professionals. This year, a key issue was the industry’s readiness to introduce compulsory medicine labelling regulations. The discussion featured representatives of all industry sectors likely to be affected by the forthcoming nationwide rollout:
  • Elena Kudryavtseva, Deputy Head of the Department for State Quality Control of Medical Products, Federal Service for Surveillance in Healthcare (Roszdravnadzor)
  • Sergey Kholkin, Pharma Area Manager, Centre for Development of Advanced Technologies
  • Margarita Mustafina, Project Manager of Teva
  • Evgeny Nifantyev, Chairman of the Coordination Council, Russian Association of Pharmacy Chains
  • Anatoly Tentser, Development Director of JSC SPC Katren
  • Mikhail Ignatov, Head of the Pharmacy Office, Moscow Department of Health
  • Vladimir Shipkov, Executive Director of the Association of International Pharmaceutical Manufacturers
  • Vadim Kukava, Executive Director of the Innovative Pharma Association of Pharmaceutical Companies
  • German Inozemtsev, General Director of PharmaSpace Drug Ecosystem

The round table was moderated by Victor Dmitriev, General Director of the Association of Russian Pharmaceutical Manufacturers (ARPM).

After a heated discussion, many attendees agreed that while the system has been built and technical solutions implemented, some issues remain to be addressed and the industry is not entirely ready. The panellists called on those present to step up their efforts in disseminating information about the project, pay attention to issues requiring intervention, and speak out more openly about problems.

FPT partnered the session ‘An effective look at the technical support of medicine production’, offering a platform to discuss the issue of efficiency at different stages of a pharmaceutical business’ life cycle and giving special attention to innovative solutions that improve efficiency.

The round table ‘Export potential: new growth points’ prompted heated debates. The panellists discussed state support measures and targets for pharmaceutical exports, growth prospects for the Eurasian Economic Union’s pharmaceutical market and its integration into the international trade system, operating procedures and creating entry points to overseas markets as exemplified by Russian and international companies.

The panellists of the round table ‘API production: the economic aspect’ – heads of Russian companies – discussed how to furnish the Russian pharmaceutical industry with high-quality, cost effective raw materials and Russian-made materials.

The 14th Pharmtechprom International Forum took place on 20-21 November, with four sessions.

In addition, leading pharmaceutical companies sponsored the PharmtechTutor, an annual educational project intended for students to consolidate existing and gain new expertise in the pharmaceutical industry. In all, 68 students from 11 Russian universities worked at the stands of 44 companies this year.

The 22nd Pharmtech & Ingredients will be held at Crocus Expo on 10–13 November 2020.

If you’d like to be part of this vital industry event, enquire today to learn about your participation options.